PDGFRA and acute myeloid leukemia: Of note, for this patient, OGM detected the FIP1L1::PDGFRA rearrangement both at diagnosis (with a central blast count of 10%, Case 4A) and in peripheral blood at the time of relapse with evolution to secondary AML (with a peripheral blast count of 92%, Case 4B).